• MJHLS Brand Logo

© 2026 MJH Life Sciences™ and The Center for Biosimilars - Biosimilars, Health Economics & Insights. All rights reserved.

Dr Scott Gottlieb Says FDA Is Monitoring Drug Device Production in Puerto Rico

In addition to challenges related to reliable power, connectivity, transportation, and clean water, Puerto Rico

On Friday, FDA Commissioner Scott Gottlieb, MD,

Related Content:

RegulatoryPolicyBusiness
Danish Registry Analysis Finds Consistent Safety After Switching to Infliximab Biosimilar GP1111
Milestone Approvals, Evolving PBM Models May Redefine the 2026 Biosimilar Landscape
FDA Draft Guidance on Biosimilars Is a Win for Patients; Now Congress Must Finish the Job